038290 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Macrogen, Inc. engages in the provision genetic research and biotechnology services. Its services include genome sequencing, oligonucleotide, microarray, genetically engineered mouse, clinical sequencing, and personal genome sequencing. The company was founded on June 5, 1997 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
038290 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company